Page last updated: 2024-08-18

phenylhydroxylamine and Neurodegenerative Diseases

phenylhydroxylamine has been researched along with Neurodegenerative Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahuja, M; Ben Aissa, M; Bourassa, MW; Gaisin, A; Gaisina, IN; Gazaryan, IG; Kaidery, NA; Lee, SH; Nikulin, SV; Poloznikov, AA; Ratan, RR; Smirnova, NN; Thatcher, GRJ; Thomas, B; Wakade, S1

Other Studies

1 other study(ies) available for phenylhydroxylamine and Neurodegenerative Diseases

ArticleYear
Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 Inhibitors.
    ACS chemical neuroscience, 2018, 05-16, Volume: 9, Issue:5

    Topics: Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Hydroxylamines; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress

2018